PATEL PRITI (Chief Medical Officer) sold 9.2% of their position (3.77K shares) of NEUROGENE INC. on the open market
Open‑market sale worth $2.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/4/2023ACC: 0001209191-23-023100
Officer· Chief Medical Officer
Since Apr 2021
-3.77K
Net shares
Net seller
$2.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10K acquired · 13.77K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
—
Trade value
—
% of position
32.2%
3/31/2023
31.08K→41.08K
Common Stock
Direct
Shares
−3.77K
Price / share
$0.69
Trade value
$2.61K
% of position
9.2%
4/3/2023
41.08K→37.31K
Total
Net shares
+6.23K
Net value
-$2.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2023 | M · Option Exercise | +10K | — | — | 32.2% | 31.08K | 41.08K |
| Common Stock Direct | 4/3/2023 | S · Sale | −3.77K | $0.69 | $2.61K | 9.2% | 41.08K | 37.31K |
| Total | +6.23K | -$2.61K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
0.00
Held after
0.00
Exercisable
—
3/31/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock10K shares | 3/31/2023 | M · Option Exercise | −10K | 0.00 | — | 0.00 |